Small Molecule Research Tools

Explore bioactive compounds by research category, then narrow your search by target, product name, catalog number or CAS.

Newly added: LC-MG and OXF molecular glue research compounds →

6,823 products17 research categoriesBrowse all products ↓

Browse by research category

Products may appear in more than one category. Counts refer to distinct catalog numbers within each category.

Other Research Tools (75) · Additional reagents, building blocks and specialized research tools.

New literature-derived products

LC-MG-1 (DCA0006) · LC-MG-4 (DCA0007) · LC-MG-9 (DCA0008)

View structure and evidence summaries →

All small molecule products

Combine a keyword, research category and target to narrow the product list.

Loading catalog filters…

6,823 products · Showing 4,801–4,848

DC8197

Tyrosine kinase inhibitor

CAS 1021950-26-4

A Tyrosine kinase inhibitor. For the detailed information of Tyrosine kinase inhibitor , the solubility of Tyrosine kinase inhibitor in water, the solubility of Tyrosine kinase inhibitor in DMSO, the solubility of Tyrosine kinase inhibitor in PBS buffer, the animal experiment (test) of Tyrosine kinase inhibitor , the cell expriment (test) of Tyrosine kinase inhibitor , the in vivo, in vitro and clinical trial test of Tyrosine kinase inhibitor , the EC50, IC50,and affinity,of Tyrosine kinase inhibitor , For the detailed information of Tyrosine kinase inhibitor , the solubility of Tyrosine kinase inhibitor in water, the solubility of Tyrosine kinase inhibitor in DMSO, the solubility of Tyrosine kinase inhibitor in PBS buffer, the animal experiment (test) of Tyrosine kinase inhibitor , the cell expriment (test) of Tyrosine kinase inhibitor , the in vivo, in vitro and clinical trial test of Tyrosine kinase inhibitor , the EC50, IC50,and affinity,of Tyrosine kinase inhibitor , Please contact DC Chemicals.

Tyrosine kinase inhibitor chemical structure
DC22823

Tariquidar methanesulfonate hydrate

CAS 625375-83-9

A potent, specific P-gp inhibitor with Kd of 5.1 nM; potentiates the cytotoxicity of several drugs including doxorubicin, paclitaxel, etoposide, and vincristine in a panel of human MDR cell lines at 25-80 nM; exhibits potent i.v. and p.o. activity without apparently enhancing the plasma pharmacokinetics of paclitaxel or the toxicity of coadministered drugs.Breast CancerPhase 2 Discontinued

Tariquidar methanesulfonate hydrate chemical structure
DC22383

Sitaxsentan

CAS 184036-34-8

A potent, long acting, orally active, selective ETA receptor antagonist that binds competitively to human ETA receptor with Ki of 0.43 nM, IC50 of 1.4 nM; dispalys >5,000-fold selectivity over ETB receptors; inhibits ET1-induced stimulation of phosphoinositide turnover with Ki of 0.686 nM, and pA2 of 8.0; excellent PK profile and oral bioavailability.HypertensionWithdrawn

Sitaxsentan chemical structure
DC22377

Pitolisant

CAS 362665-56-3

A potent and selective antagonist of H3 receptor with Ki/EC50 of 0.16/1.5 nM; no effect on H1, H2, H4 receptors (IC50>10 uM); orally bioactive.Sleep DisorderApproved

Pitolisant chemical structure
DC22622

WAY-100635

CAS 162760-96-5

A potent and selective 5-HT1A receptor antagonist; also acts as potent full agonist at the D4 receptor; completely prevents not only the hyperpolarization, with an IC50 of 1.3 nM, but also the decrease in membrane input resistance produced by 5-HT and 5-carboxamidotryptamine with IC50 of 22.5 μM and 50 nM, respectively. AnxietyPhase 1 Discontinued

WAY-100635 chemical structure
DCAPI1556

Cinchocaine HCL

CAS 61-12-1

For the detailed information of Cinchocaine HCL, the solubility of Cinchocaine HCL in water, the solubility of Cinchocaine HCL in DMSO, the solubility of Cinchocaine HCL in PBS buffer, the animal experiment(test) (test) of Cinchocaine HCL, the cell expriment (test) of Cinchocaine HCL, the in vivo, in vitro and clinical trial test of Cinchocaine HCL, the EC50, IC50,and Affinity of Cinchocaine HCL,, please contact DC Chemicals.

Cinchocaine HCL chemical structure
DCN-020

Urea

CAS 57-13-6

For the detailed information of Urea, the solubility of Urea in water, the solubility of Urea in DMSO, the solubility of Urea in PBS buffer, the animal experiment(test) (test) of Urea, the cell expriment (test) of Urea, the in vivo, in vitro and clinical trial test of Urea, the EC50, IC50,and Affinity of Urea,, please contact DC Chemicals.

Urea chemical structure
DCL-076

3,4-Dimethoxybenzyl alcohol

CAS 93-03-8

For the detailed information of 3,4-Dimethoxybenzyl alcohol, the solubility of 3,4-Dimethoxybenzyl alcohol in water, the solubility of 3,4-Dimethoxybenzyl alcohol in DMSO, the solubility of 3,4-Dimethoxybenzyl alcohol in PBS buffer, the animal experiment(test) (test) of 3,4-Dimethoxybenzyl alcohol, the cell expriment (test) of 3,4-Dimethoxybenzyl alcohol, the in vivo, in vitro and clinical trial test of 3,4-Dimethoxybenzyl alcohol, the EC50, IC50,and Affinity of 3,4-Dimethoxybenzyl alcohol,, please contact DC Chemicals.

3,4-Dimethoxybenzyl alcohol chemical structure
DCL-062

3,4-Dimethoxybenzoic acid

CAS 93-07-2

For the detailed information of 3,4-Dimethoxybenzoic acid, the solubility of 3,4-Dimethoxybenzoic acid in water, the solubility of 3,4-Dimethoxybenzoic acid in DMSO, the solubility of 3,4-Dimethoxybenzoic acid in PBS buffer, the animal experiment(test) (test) of 3,4-Dimethoxybenzoic acid, the cell expriment (test) of 3,4-Dimethoxybenzoic acid, the in vivo, in vitro and clinical trial test of 3,4-Dimethoxybenzoic acid, the EC50, IC50,and Affinity of 3,4-Dimethoxybenzoic acid,, please contact DC Chemicals.

3,4-Dimethoxybenzoic acid chemical structure
DCK-013

Caffeine

CAS 58-08-2

For the detailed information of Caffeine, the solubility of Caffeine in water, the solubility of Caffeine in DMSO, the solubility of Caffeine in PBS buffer, the animal experiment(test) (test) of Caffeine, the cell expriment (test) of Caffeine, the in vivo, in vitro and clinical trial test of Caffeine, the EC50, IC50,and Affinity of Caffeine,, please contact DC Chemicals.

Caffeine chemical structure
DCY-148

Guaiacol

CAS 90-05-1

For the detailed information about the solubility of Guaiacol in water, the solubility of Guaiacol in DMSO, the solubility of Guaiacol in PBS buffer, the animal experiment(test) of Guaiacol,the in vivo,in vitro and clinical trial test of Guaiacol,the cell experiment(test) of Guaiacol,the IC50, EC50 and Affinity of Guaiacol, please contact DC Chemicals.

Guaiacol chemical structure
DCK-009

Theobromine

CAS 83-67-0

For the detailed information of Theobromine, the solubility of Theobromine in water, the solubility of Theobromine in DMSO, the solubility of Theobromine in PBS buffer, the animal experiment(test) (test) of Theobromine, the cell expriment (test) of Theobromine, the in vivo, in vitro and clinical trial test of Theobromine, the EC50, IC50,and Affinity of Theobromine,, please contact DC Chemicals.

Theobromine chemical structure
DCB-083

Benzaldehyde

CAS 100-52-7

For the detailed information of Benzaldehyde, the solubility of Benzaldehyde in water, the solubility of Benzaldehyde in DMSO, the solubility of Benzaldehyde in PBS buffer, the animal experiment(test) (test) of Benzaldehyde, the cell expriment (test) of Benzaldehyde, the in vivo, in vitro and clinical trial test of Benzaldehyde, the EC50, IC50,and Affinity of Benzaldehyde,, please contact DC Chemicals.

Benzaldehyde chemical structure
DCX-060

Adenine

CAS 73-24-5

For the detailed information about the solubility of Adenine in water, the solubility of Adenine in DMSO, the solubility of Adenine in PBS buffer, the animal experiment(test) of Adenine,the in vivo,in vitro and clinical trial test of Adenine,the cell experiment(test) of Adenine,the IC50, EC50 and Affinity of Adenine, please contact DC Chemicals.

Adenine chemical structure
DCB-080

Cytosine

CAS 71-30-7

For the detailed information of Cytosine, the solubility of Cytosine in water, the solubility of Cytosine in DMSO, the solubility of Cytosine in PBS buffer, the animal experiment(test) (test) of Cytosine, the cell expriment (test) of Cytosine, the in vivo, in vitro and clinical trial test of Cytosine, the EC50, IC50,and Affinity of Cytosine,, please contact DC Chemicals.

Cytosine chemical structure
DCN-024

Uracil

CAS 66-22-8

For the detailed information of Uracil, the solubility of Uracil in water, the solubility of Uracil in DMSO, the solubility of Uracil in PBS buffer, the animal experiment(test) (test) of Uracil, the cell expriment (test) of Uracil, the in vivo, in vitro and clinical trial test of Uracil, the EC50, IC50,and Affinity of Uracil,, please contact DC Chemicals.

Uracil chemical structure
DCG-026

Glycine

CAS 56-40-6

For the detailed information of Glycine, the solubility of Glycine in water, the solubility of Glycine in DMSO, the solubility of Glycine in PBS buffer, the animal experiment(test) (test) of Glycine, the cell expriment (test) of Glycine, the in vivo, in vitro and clinical trial test of Glycine, the EC50, IC50,and Affinity of Glycine,, please contact DC Chemicals.

Glycine chemical structure
DCL-018

2-Methoxycinnamic acid

CAS 6099-03-2

For the detailed information of 2-Methoxycinnamic acid, the solubility of 2-Methoxycinnamic acid in water, the solubility of 2-Methoxycinnamic acid in DMSO, the solubility of 2-Methoxycinnamic acid in PBS buffer, the animal experiment(test) (test) of 2-Methoxycinnamic acid, the cell expriment (test) of 2-Methoxycinnamic acid, the in vivo, in vitro and clinical trial test of 2-Methoxycinnamic acid, the EC50, IC50,and Affinity of 2-Methoxycinnamic acid,, please contact DC Chemicals.

2-Methoxycinnamic acid chemical structure
DC23552

AS-2444697 HCl

CAS 1287665-60-4

A potent, selective, orally bioavailable IRAK-4 inhibitor that potently inhibits human and rat IRAK-4 activity with subnanomolar order, >30-fold selectivity over IRAK-1; inhibited IL-1β- or TLR ligand lipopolysaccharide (LPS)-induced IL-6 production in human lung alveolar epithelial cells, fibroblast-like synoviocytes, and peripheral blood mononuclear cells; significantly reduces urinary protein excretion and preventd the development of glomerulosclerosis and interstitial fibrosis without affecting the blood pressure in mice model of chronic kidney disease.

AS-2444697 HCl chemical structure
DC68203

APE1-IN-1

CAS 524708-03-0

APE1-IN-1 is a potent and blood-brain barrier (BBB) penetrant apurinic/apyrimidinic (AP) endonuclease 1 (APE1) inhibitor with an IC50 value of 2 μM. APE1-IN-1 can potentiate the cytotoxicity of the alkylating agents Methylmethane sulfonate and Temozolomide (HY-17364) to cancer cell.

APE1-IN-1 chemical structure
DC9371

5-FAM SE

CAS 92557-80-7

5-FAM SE is a single isomer, it is one of the most popular green fluorescent reagents used for labeling peptides, proteins and nucleotides. It has also been used to prepare various small fluorescent molecules.

5-FAM SE chemical structure
DC60092

PXS-5505

CAS 2409963-83-1

DWN63831 is a lysyl oxidase inhbitor. DWN63831 may be useful in treatment of a variety of disorders, e.g., fibrosis, cancer and angiogenesis in human subjects as well as in pets and livestock. DWN63831 was first reported in patent WO 2020024017.

PXS-5505 chemical structure
DC10831

HS-27

CAS 1562024-11-6

Hs-27 is a Novel Hsp90 Inhibitor, Exhibits Diagnostic and Therapeutic Potential in Triple Negative Breast Cancer.

HS-27 chemical structure
DC1058

LY294002

CAS 154447-36-6

LY294002 is a broad-spectrum inhibitor of PI3K with IC50s of 0.5, 0.57, and 0.97 μM for PI3Kα, PI3Kδ and PI3Kβ, respectively. It also inhibits CK2 with an IC50 of 98 nM.

LY294002 chemical structure
DCAPI1015

Zafirlukast(Accolate)

CAS 107753-78-6

For the detailed information of Zafirlukast(Accolate), the solubility of Zafirlukast(Accolate) in water, the solubility of Zafirlukast(Accolate) in DMSO, the solubility of Zafirlukast(Accolate) in PBS buffer, the animal experiment(test) (test) of Zafirlukast(Accolate), the cell expriment (test) of Zafirlukast(Accolate), the in vivo, in vitro and clinical trial test of Zafirlukast(Accolate), the EC50, IC50,and Affinity of Zafirlukast(Accolate),, please contact DC Chemicals.

Zafirlukast(Accolate) chemical structure
DC7725

TH 287

CAS 1609960-30-6

TH287 is a potent inhibitor of MTH1 (NUDT1) with an IC50 value of 0.8 nM, less potent for MTH2, NUDT5, NUDT12, NUDT14, and NUDT16.TH287 is considered a new target for cancer therapy. TH287 is highly selective towards MTH1, with no relevant inhibition of other members of the nudix protein family. TH287 has been shown to selectively kill a variety of cancer cell lines, but is rapidly metablized, so not as useful for in vivo studies.

TH 287 chemical structure
DC42708

AZ3976

CAS 1418747-15-5

AZ3976 is a selective PAI-1 inhibitor that exhibits potent profibrinolytic effects, with IC50 values of 26 μM (chromogenic assay) and 16 μM (plasma clot lysis assay). Unlike conventional inhibitors, it does not target active PAI-1 but instead binds reversibly to the latent form, accelerating the transition of active PAI-1 to its inactive state.

AZ3976 chemical structure
DC22180

NPD8733

CAS 696655-62-6

NPD8733 (NPD-8733) is a small-molecule ligand of valosin-containing protein (VCP)/p97, binds to the D1 domain of VCP/p97; suppresses the enhanced migration of NIH3T3 cells co-cultured with MCF7 cells using a wound healing co-culture assay.

NPD8733 chemical structure
Browse target & topic index A–Z (366)
11β-HSD (1)15-PGDH (2)5-HT Receptor (16)Acetyl-CoA Carboxylase (ACC) (3)Acetylcholinesterase (AChE) (2)Ack1 (TNK2) (1)Acyltransferase (1)ADC Cytotoxin (6)ADCs Linker/Click Chemistry (5)Adenosine Receptor (9)Adenylate Cyclase (2)Adrenergic Receptor (11)Akt (12)Alcoholism (2)Aldehyde Dehydrogenase (ALDH) (6)Allergy (5)Alzheimer Disease (13)Aminopeptidase (1)AMPK (8)Amyloids (4)Anaplastic Lymphoma Kinase (ALK) (9)Androgen Receptor (AR) (11)Anemia (4)Angiotensin Receptor (4)Antibody/Protein labeling dyes (1)Antifolate (2)Anxiety (1)Apoptosis Inducer (3)Arginase (1)Arp2/3 complex (1)Aryl hydrocarbon Receptor (AhR) (1)Asthma (5)Atherosclerosis (2)ATM/ATR (8)Aurora Kinase (10)Autophagy (6)Autophagy-related Protein (Atg) (2)Autotaxin (2)Bacterial (26)Bacterial Infection (17)Bcl-2 (14)Bcr-Abl (5)BCRP (1)Beta-catenin (4)Beta-secretase (BACE) (4)Blood Cancer (91)BMI-1 (1)Bone Cancer (6)Brain Cancer (6)Breast Cancer (30)Bromodomain (22)BTK (10)c-Fms (CSF1R) (5)c-Fos/AP-1 (1)c-Kit (6)c-Met (HGFR) (11)c-Myc (2)Calcium Channel (4)Calcium-sensing Receptor (CaSR) (1)CaMK (4)Cannabinoid Receptor (6)Carbonic Anhydrase (1)Carboxypeptidase (1)Casein Kinase (6)Caspase (4)Cathepsin (6)Cdc2-like Kinase (CLK) (1)CETP (2)CFTR (7)Checkpoint Kinase (Chk) (8)Chemokine Receptor (CCR and CXCR) (14)Chemotherapeutic Agents (19)Chloride Channel (1)CMV (2)CMV Infection (2)Colon Cancer (9)Complement System (1)COPD (3)CREB/CBP (2)CRF Receptor (2)CRISPR/Cas9 (1)Cushing Disease (1)Cyclin-dependent Kinase (CDK) (39)Cyclooxygenase (COX) (4)Cytochrome P450 (CYPs) (5)Depression (2)Dermatitis (2)Deubiquitinase (DUB) (7)Diabetes (20)Dipeptidyl Peptidase (DPP) (3)Discoidin Domain Receptor (DDR) (1)DNA Alkylator/Crosslinker (10)DNA Methyltransferase (DNMT) (1)DNA Repair Protein (1)DNA-PK (2)DNA/RNA Synthesis (5)Dopamine beta-hydroxylase (1)Dopamine Receptor (7)Drug Metabolite (1)Drug-Linker Conjugates (11)Dyes (4)DYRK (1)Dyslipidemia (9)E3 Ligase Ligand (6)E3 Ligase Ligand-Linker Conjugate (1)E3 Ubiquitin Ligase (4)Ebola Virus Infection (1)EGFR (32)Elastase (2)Endothelin Receptor (5)Enzymes substrates (13)Epigenetic Reader Domain (3)Epilepsy (4)ERK (4)Estrogen Receptor/ERR (13)Eukaryotic Initiation Factor (eIF) (2)Exportin-1 (CRM1,XPO1) (2)FABP (1)Factor Xa (5)Farnesoid X Receptor (FXR) (5)Farnesyl transferase (FTase) (1)Ferroptosis (6)FGFR (20)Fibrosis (5)FLT3 (6)Focal Adhesion Kinase (FAK) (11)Foxo1 (1)Free Fatty Acid Receptor (FFAR) (5)Fungal (2)Fungal Infection (1)GABA Receptor (13)Galectin (1)Gastric Cancer (8)Ghrelin Receptor (GHSR) (3)Glucagon Receptor (4)Glucokinase (2)Glucose Transporter (GLUT) (2)Glutamate Transporter (2)GPCR (1)GPER (GPR30) (1)GPR139 (1)GPR183 (EBI2) (2)GPR39 (1)GPR55 (1)GPR84 (1)GRK (GPCRK) (2)Growth Hormone Deficiency (2)GSK-3 (8)Guanylate Cyclase (3)HBV (1)HBV Infection (1)HCN Channel (2)HCV (8)HCV Infection (9)HDAC (38)Heart Arrhythmia (2)Heart Failure (5)Heat Shock Protein (HSP) (15)Hedgehog (Hh) (1)HIF/HIF Prolyl-hydroxylase (8)Histamine Receptor (6)Histone Acetyltransferase (HAT) (5)Histone Demethylase (11)Histone Methyltransferase (HMTase) (31)HIV (12)HIV Infection (11)HMG-CoA Reductase (HMGCR) (3)HSV (1)HSV Infection (1)Hypercholesterolemia (1)Hyperparathyroidism (1)Hypertension (8)IAP (1)IGF-1R (3)iGluR (15)Indoleamine 2,3-Dioxygenase (IDO) (4)Infection (1)Influenza (6)Influenza Virus (6)Insulin Receptor (2)Integrin (6)Interleukin Receptor (1)IRAK (2)IRE1 (4)Irritable Bowel Syndrome (2)Ischemia (1)Isocitrate Dehydrogenase (IDH) (5)ITK (1)IκB kinase (IKK) (7)JAK (32)JNK (3)Keap1-Nrf2 (6)Kidney Cancer (10)Kinesin (5)Kruppel-like Factor (KLF) (1)Kynurenine 3-Monooxygenase (KMO) (1)Leukotriene Receptor (1)LIM Kinase (LIMK) (3)Lipids fragment (1)Liver Cancer (6)Liver X Receptor (LXR) (3)LRRK2 (9)Lung Cancer (39)Lysophospholipid Receptor (12)LYTACs (3)mAChR (9)MALT1 (2)MAP4K (1)Matrix Metalloproteinase (MMP) (10)MDM2-p53 (9)MEK (MAP2K) (14)MEKK (MAP3K) (1)Melanocortin Receptor (2)MELK (1)mGluR (7)MicroRNA (1)Microtubule/Tubulin (5)Mineralocorticoid Receptor (MLR) (1)MITF (1)Mixed Lineage Kinase (MLK) (3)MNK (2)Molecular Glues (21)Monoamine Transporter (5)Monocarboxylate Transporter (MCT) (1)Monopolar Spindle 1 (Mps1/TTK) (3)mTOR (13)Multiple Sclerosis (6)Myosin (1)Na-K-Cl Cotransporter (NKCC) (2)nAChR (2)NADPH Oxidase (NOX) (2)NAMPT (3)Natural products (37)Neprilysin (1)Neurokinin Receptor (3)Neuropeptide Y Receptor (3)NF-κB (5)Nitric Oxide Synthase (NOS) (1)NOD-like Receptor (NLR) (3)Notch (2)Nucleoside Antimetabolite/Analog (10)Nur77 (NR4A1) (1)Obesity (1)Oct3/4 (1)Opioid Receptor (5)Orexin Receptor (7)Osteoporosis (2)Ovarian Cancer (14)Oxytocin Receptor (OXTR) (2)P-glycoprotein (P-gp) (3)p21-activated Kinase (PAK) (1)P2X Receptor (2)P2Y Receptor (1)p38 MAPK (10)p97/VCP (1)Pain (12)Pancreatic Cancer (10)Parasite (5)Parasite Infection (2)Parkinson Disease (2)PARP (19)PCSK9 (1)PD-1/PD-L1 (4)PDGFR (4)PDK1 (2)PEGn (1)PERK (2)PGE synthase (2)Phosphodiesterase (PDE) (9)Phospholipase (4)PI3K (32)PI4K (2)Piezo Channel (1)PIKfyve (3)Pim (9)PKC (12)PKD (1)Plasminogen Activator Inhibitor-1 (PAI-1) (3)Polo-like Kinase (PLK) (4)Porcupine (3)Potassium Channel (13)PPAR (13)Pregnane X Receptor (PXR) (1)Progesterone Receptor (2)Prostaglandin Receptor (11)Prostate Cancer (7)PROTACs (35)Protease-activated Receptor (PAR) (3)Proteasome (12)Protein Disulfide Isomerase (PDI) (1)Protein Phosphatase/PTP (6)Proton Pump (1)Psoriasis (5)RAD51 (1)Radioligand precursors (15)Raf (18)RAR/RXR (3)Ras (17)Renin (2)RET Tyrosine Kinase (c-RET) (3)Rheumatoid Arthritis (16)Ribosomal S6 Kinase (RSK) (5)RIG-I-like Receptor (RLR) (2)RIP kinase (7)ROCK (12)ROR (2)RSV (4)RSV Infection (3)RUNX1-CBFβ (1)S-nitrosoglutathione reductase (GSNOR) (1)Saccharides and Glycosides (1)Salt Inducible Kinase (SIK) (2)SARS-CoV (16)SARS-CoV Infection (34)Schizophrenia (4)Sexual Dysfunction (1)SGLT (4)Sigma Receptor (4)Sirtuin (9)Skin Cancer (13)Sleep Disorder (7)SMN2 Modulator (1)Smoothened (Smo) (9)Sodium Channel (12)Solid Tumors (35)Somatostatin Receptor (2)Sphingosine kinase (SphK) (2)Src (7)STAT (5)Stearoyl-CoA Desaturase (SCD) (1)Steatohepatitis (7)Sterol lipids (1)STING (14)Syk (6)T Cell Receptor (TCR) (1)TAK1 (2)TAM Receptor (Tyro3-Axl-Mer) (4)Taste Receptor (1)Telomerase (2)TGF beta Receptor (TGFBR) (12)Thrombin (3)Thrombosis (13)Thyroid Cancer (1)Thyroid Hormone Receptor (THR) (1)Thyrotropin Receptor (2)TNIK (1)Toll-like Receptor (TLR) (2)TOPK (1)Topoisomerase (11)TRAIL (1)Translocator Protein (TSPO) (1)Trk Receptor (4)TRP Channel (13)Tryptophan Hydroxylase (TPH) (1)Ubiquitin-activating Enzyme (E1) (2)Ubiquitin-conjugating Enzyme (E2) (2)Ulcer (1)ULK (3)Vasopressin Receptor (2)VEGFR (25)Vitamin D Receptor (VDR) (3)Wee1 (1)WNK Kinase (1)Wnt (5)Yes-associated Protein (YAP) (4)γ-secretase (5)

Cart

Request quotation